News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Human Genome Sciences (HGSI) Incyte (INCY) Mirati Therapeutics (MRTX) Endometrial Cancer Advaxis (ADXS) Ariad (ARIA) CEMPRA (CEMP) Roche (ROCHE) NANTKWEST (NK) ISIS (ISIS) Dynavax (DVAX) ABBVIE (ABBV) Velcade (bortezomib) Cytokinetics (CYTK) HALOZYME (HALO) Vitae Pharmaceuticals (VTAE) Ziofpharm (ZIOP) AGOS (ARGS) Galena (GALE) Rapamune ARCA (ABIO) Sequenom (SQNM) Anadys (ANDS) Human Longevity (HLI) ADVENTRIX (ANX) Amgen (AMGN) PTC Therapeutics (PTCT) Auspex (ASPX) RenenxBio (RGNX) Sarepta (SRPT) Intermune (ITMN) AERIE PHARMACEUTICALS VANDA (VNDA) NOVOCURE (NVCR) Roche (RHHBY) KITE (KITE) CRISPR Therapeutics (CRSP) Prolor Biotech (PBTH) JUNO (JUNO) Micromet (MITI) ARGOS (ARGS) IDERA (IDRA) Ocular Therapeutix (OCUL) Vertex (VRTX) Bristol-Myers Squibb (BMY) REGULUS (RGLS) Inovio (INO) Editas (EDIT) Revlimid (lenolidamide) Seattle Genetics (SGEN) Merck (MRK) Tysabri INNOVIVA (INVA) Telaprevir Biocryst (BCRX) C4 Therapeutics Jazz Pharmaceuticals (JAZZ) Abbott Laboratories (ABT) Elan (ELN) Adaptimmune (ADAP) Agenus (AGEN Intrexon (XON) Valeant Pharmaceuticals International (VRX) CompuGen (CGEN) Regeneron (REGN) SYNTA (SNTA) Pluristem (PSTI) GlaxoSmithKline (GSK) Aimmune Therapeutics (AIMT) Illumina (ILMN) Trastuzumab-DM1 galapagos (GLPG) Alder Biopharmaceuticals (ALDR) ZALTRAP™ Theravance (THRX) MODERNA Intercept (ICPT) Agenus (AGEN) AstraZeneca (AZN) Sanofi-Aventis (SAN) Dendreon (DNDN) BIOMARIN (BMRN) Exelixis (EXEL) OSI (OSIP) Xoma (XOMA) Sanofi (SNY) NEKTAR (NKTR)) Ridaforolimus Alnylam (ALNY) Genentech ACADIA (ACAD) TOKAI (TKAOI) Sangamo (SGMO) Prosensa (RNA) Array Pharmaceuticals (ARRY) KERYX (KERX) Herceptin GUARDIAN HEALTH Anacor (ANAC) Ionis (IONS) Benlysta (belimumab) ImmunoGen (IMGN) Idenix (IDIX) SERES THERAPEUTICS (MCRB) Gilead (GILD) Sanofi (SNA) Multiple Myeloma Onyx (ONXX) Theravance Bio Pharma (TBPH) Bellicum (BLCM) Global Cell Therapeutics (GBT) Zerenex Spike Therapeutics (ONCE) Biogen Idec (BIIB) SUNESIS PHARMACEUTICALS (SNSS)